Bristol-Myers Squibb Company (BMY): All Or Nothing With A Breakthrough Drug, Says Jim Cramer
Bristol-Myers Squibb Company (NYSE:BMY) is one of the largest and most well-known American pharmaceutical companies. It has long been one of Cramer's favorite stocks as the CNBC TV host has been nothing but full of optimism about its COBENFY schizophrenia drug. However, during this show, he changed his tone and pinned all hopes on COBENFY's success:
'[Report about the two selling Eliquis at a discount] Yeah, I mean, mistakes I've made a few but, today I'm looking at Bristol, Bristol better come through with this. With this mental health, with this mental health drug that they bought, the schizophrenic drug. . . .I mean Bristol is uh, Bristol's bad. And I own it. I own it because of this schizophrenia drug. And I said yesterday to the club, they get this schizophrenia drug, I'm going with it. They don't get this schizophrenia drug, I've never heard of it. That's where I am. Never heard of Bristol-Myers.'
A pharmacy shelves stocked with pharmaceutical drugs awaiting distribution.
Previously, Cramer discussed Bristol-Myers Squibb Company (NYSE:BMY)'s 'faint pulse':
'Of course, some of the rally's nothing more than the left-behind stocks playing catch up. The drug stocks had a rare day in the sun. I wish I had something good to say about them. Maybe it's enough to say that Bristol Myers has a faint pulse, one that lasted until the end of the session.'
While we acknowledge the potential of BMY as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the .
READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.
Disclosure: None. This article is originally published at Insider Monkey.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 minutes ago
- Yahoo
Corn Facing Pressure to Start New Week
Corn price action is 1 to 2 cents lower on Monday morning. Futures closed out the Friday session with contracts 2 to 3 cents in the red as forecasts remain wet. September was down 9 cents on the week. Preliminary open interest suggested net new selling, up 19,204 contracts on Friday. The CmdtyView national average new crop Cash Corn price was down 2 1/4 cents at $3.77 As we round out July and start August, rain is expected to make its way from the northern Plains most of the Eastern Corn Belt in the next week, with 1 to 2 inches. CFTC data from Friday afternoon showed a total of 2,610 contracts added back to the net short in the managed money position as of July 22 to 177,365 contracts. More News from Barchart Does the 2025 Corn Crop Have a Pollination Problem? Our exclusive Barchart Brief newsletter is your FREE midday guide to what's moving stocks, sectors, and investor sentiment - delivered right when you need the info most. Subscribe today! Weekly Export Sales data has total corn export commitments at 70.110 MMT, which is above the USDA estimate for the full year and compared to the 102% average pace by now. Exports are now 60.172 MMT, or 86% of the USDA number and behind the 89% average. Over the weekend, President Milei of Argentina announced a reduction in the export tax for corn back to 9.5%, from 12%. AgRural estimates the Brazilian second corn crop at 68% harvested as of Thursday, shy of the 91% complete from the same week last year.. Sep 25 Corn closed at $3.99 1/2, down 2 1/4 cents, currently down 1 1/4 cents Nearby Cash was $3.84 1/1, down 3 cents, Dec 25 Corn closed at $4.19, down 1 3/4 cents, currently down 1 1/2 cents Mar 26 Corn closed at $4.36 1/2, down 1 3/4 cents, currently down 2 cents New Crop Cash was $3.77, down 2 1/4 cents, On the date of publication, Austin Schroeder did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on
Yahoo
5 minutes ago
- Yahoo
Here's What Lifted Olo (OLO) in Q2
Conestoga Capital Advisors, an asset management company, released its second-quarter 2025 investor letter. A copy of the letter can be downloaded here. The second quarter began with a historically poor start but gained momentum later as tariff fears subsided and market volatility dropped precipitously. Conestoga Micro Cap Composite appreciated 15.65% net-of-fees in the second quarter but underperformed the Russell Microcap Growth Index's 20.92% return. In a highly volatile market led by high-beta and lower-quality stocks, the firm does not expect the fund to align with index performance. Please review the fund's top 5 holdings to gain insight into their key selections for 2025. In its second quarter 2025 investor letter, Conestoga Capital Advisors highlighted stocks such as Olo Inc. (NYSE:OLO). Headquartered in New York, New York, Olo Inc. (NYSE:OLO) offers a SaaS platform for restaurants. The one-month return of Olo Inc. (NYSE:OLO) was 13.93%, and its shares gained 117.60% of their value over the last 52 weeks. On July 25, 2025, Olo Inc. (NYSE:OLO) stock closed at $10.14 per share, with a market capitalization of $1.714 billion. Conestoga Capital Advisors stated the following regarding Olo Inc. (NYSE:OLO) in its second quarter 2025 investor letter: "Olo Inc. (NYSE:OLO) is a SaaS technology platform that enables it's greater than 700 restaurant brand customers to reach their customers across over 85,000 locations. OLO has been a leader in two of the past three quarters. In its 1Q earnings report, OLO announced a major win with the Chipotle restaurant chain. Also, during the quarter, OLO announced that Red Lobster had come back to their platform after attempting to build their own solution but realizing OLO was a better option. There was also speculation during the quarter that OLO could be considering strategic alternatives, which contributed to the stock gains." A business executive showcasing a mobile ordering app to a busy restaurant staff. Olo Inc. (NYSE:OLO) is not on our list of 30 Most Popular Stocks Among Hedge Funds. According to our database, 27 hedge fund portfolios held Olo Inc. (NYSE:OLO) at the end of the first quarter compared to 30 in the previous quarter. In the first quarter of 2025, Olo Inc. (NYSE:OLO) generated total revenue of $80.7 million, reflecting an increase of 21% year-over-year. While we acknowledge the potential of Olo Inc. (NYSE:OLO) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. In another article, we covered Olo Inc. (NYSE:OLO) and shared the list of best overlooked stocks that pay dividends. In addition, please check out our hedge fund investor letters Q2 2025 page for more investor letters from hedge funds and other leading investors. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
5 minutes ago
- Yahoo
Carlyle picks insiders for newly minted role of co-presidents after reshuffle
(Reuters) -Alternative asset manager Carlyle said on Monday it has rejigged its senior leadership ranks and named three of its veterans for its newly created role of co-presidents. Chief Financial Officer John Redett, credit head Mark Jenkins and client business head Jeff Nedelman will become the company's co-presidents, effective January 1, 2026. "These individuals, all Carlyle veterans, are proven leaders whose deep expertise and extensive experience will drive our next phase of growth," CEO Harvey Schwartz said in a statement. Since Schwartz took the helm in 2023, Carlyle has undergone a multi-year transformation to boost growth by rejigging leadership and realigning its compensation model, while expanding beyond its private equity roots. The company said the leadership appointments would bolster its ability to operate at scale in a competitive environment. In the newly created roles, the trio will closely work with Schwartz to further Carlyle's growth ambitions, the firm said. In addition to their new roles, Jenkins will lead the credit and insurance business, while Nedelman will continue to head the client business. Redett will lead Carlyle's private equity business as well as oversee the corporate private equity and real assets businesses. Justin Plouffe, who is the current deputy chief investment officer for Carlyle's credit business, will succeed Redett as the finance boss of Carlyle next year, the company said. Michael Wand, who oversees the firm's private equity business in Europe, will become the head of EMEA investments and work in tandem with the company's co-presidents. Admiral James Stavridis, the former Supreme Allied Commander at NATO and Carlyle's vice chair of global affairs, will become the company's vice chairman. With $453 billion of assets under management, Carlyle deploys private capital across private equity, credit and its AlpInvest business. Carlyle is set to report its quarterly results next week. Its stock has jumped nearly 26% this year. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
